Copyright Reports & Markets. All rights reserved.

Global Cancer Targeted Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cancer Targeted Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Tumor Antigens As Targets of Antibodies
      • 1.4.3 Development of Antibodies for Clinical Purposes
      • 1.4.4 Complement Dependent Cytotoxicity (CDC)
      • 1.4.5 Signal Transduction Changes
    • 1.5 Market by Application
      • 1.5.1 Global Cancer Targeted Therapy Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cancer Targeted Therapy Market Size
    • 2.2 Cancer Targeted Therapy Growth Trends by Regions
      • 2.2.1 Cancer Targeted Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Cancer Targeted Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Cancer Targeted Therapy Market Size by Manufacturers
      • 3.1.1 Global Cancer Targeted Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Cancer Targeted Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Cancer Targeted Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cancer Targeted Therapy Key Players Head office and Area Served
    • 3.3 Key Players Cancer Targeted Therapy Product/Solution/Service
    • 3.4 Date of Enter into Cancer Targeted Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cancer Targeted Therapy Market Size by Type (2014-2019)
    • 4.2 Global Cancer Targeted Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cancer Targeted Therapy Market Size (2014-2019)
    • 5.2 Cancer Targeted Therapy Key Players in United States
    • 5.3 United States Cancer Targeted Therapy Market Size by Type
    • 5.4 United States Cancer Targeted Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Cancer Targeted Therapy Market Size (2014-2019)
    • 6.2 Cancer Targeted Therapy Key Players in Europe
    • 6.3 Europe Cancer Targeted Therapy Market Size by Type
    • 6.4 Europe Cancer Targeted Therapy Market Size by Application

    7 China

    • 7.1 China Cancer Targeted Therapy Market Size (2014-2019)
    • 7.2 Cancer Targeted Therapy Key Players in China
    • 7.3 China Cancer Targeted Therapy Market Size by Type
    • 7.4 China Cancer Targeted Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Cancer Targeted Therapy Market Size (2014-2019)
    • 8.2 Cancer Targeted Therapy Key Players in Japan
    • 8.3 Japan Cancer Targeted Therapy Market Size by Type
    • 8.4 Japan Cancer Targeted Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cancer Targeted Therapy Market Size (2014-2019)
    • 9.2 Cancer Targeted Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Cancer Targeted Therapy Market Size by Type
    • 9.4 Southeast Asia Cancer Targeted Therapy Market Size by Application

    10 India

    • 10.1 India Cancer Targeted Therapy Market Size (2014-2019)
    • 10.2 Cancer Targeted Therapy Key Players in India
    • 10.3 India Cancer Targeted Therapy Market Size by Type
    • 10.4 India Cancer Targeted Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cancer Targeted Therapy Market Size (2014-2019)
    • 11.2 Cancer Targeted Therapy Key Players in Central & South America
    • 11.3 Central & South America Cancer Targeted Therapy Market Size by Type
    • 11.4 Central & South America Cancer Targeted Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Advaxis
      • 12.1.1 Advaxis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cancer Targeted Therapy Introduction
      • 12.1.4 Advaxis Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.1.5 Advaxis Recent Development
    • 12.2 Bind Therapeutics
      • 12.2.1 Bind Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cancer Targeted Therapy Introduction
      • 12.2.4 Bind Therapeutics Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.2.5 Bind Therapeutics Recent Development
    • 12.3 Boehringer Ingelheim
      • 12.3.1 Boehringer Ingelheim Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cancer Targeted Therapy Introduction
      • 12.3.4 Boehringer Ingelheim Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.3.5 Boehringer Ingelheim Recent Development
    • 12.4 Bristol Mayer Squibb
      • 12.4.1 Bristol Mayer Squibb Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cancer Targeted Therapy Introduction
      • 12.4.4 Bristol Mayer Squibb Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.4.5 Bristol Mayer Squibb Recent Development
    • 12.5 Celldex Therapeutics
      • 12.5.1 Celldex Therapeutics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cancer Targeted Therapy Introduction
      • 12.5.4 Celldex Therapeutics Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.5.5 Celldex Therapeutics Recent Development
    • 12.6 Dendreon Corporation
      • 12.6.1 Dendreon Corporation Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cancer Targeted Therapy Introduction
      • 12.6.4 Dendreon Corporation Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.6.5 Dendreon Corporation Recent Development
    • 12.7 Eli Lily
      • 12.7.1 Eli Lily Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cancer Targeted Therapy Introduction
      • 12.7.4 Eli Lily Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.7.5 Eli Lily Recent Development
    • 12.8 GalaxoSmithKline
      • 12.8.1 GalaxoSmithKline Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Cancer Targeted Therapy Introduction
      • 12.8.4 GalaxoSmithKline Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.8.5 GalaxoSmithKline Recent Development
    • 12.9 Galena Biopharma
      • 12.9.1 Galena Biopharma Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Cancer Targeted Therapy Introduction
      • 12.9.4 Galena Biopharma Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.9.5 Galena Biopharma Recent Development
    • 12.10 Genetech
      • 12.10.1 Genetech Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Cancer Targeted Therapy Introduction
      • 12.10.4 Genetech Revenue in Cancer Targeted Therapy Business (2014-2019)
      • 12.10.5 Genetech Recent Development
    • 12.11 ImmunoCellular Therapeutics
    • 12.12 ImmunoGen
    • 12.13 Inovio Pharmaceuticals
    • 12.14 Johnson & Johnson
    • 12.15 NeoStem Oncology
    • 12.16 NewLink Genetics
    • 12.17 Northwest Biotherapeutics
    • 12.18 Merck
    • 12.19 Novartis
    • 12.20 Peregrine Pharmaceuticals
    • 12.21 Pfizer
    • 12.22 Roche
    • 12.23 Sanofi
    • 12.24 Seattle Genetics
    • 12.25 Teva

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Cancer Targeted Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Cancer Targeted Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Targeted Therapy development in United States, Europe and China.

      The key players covered in this study
      Advaxis
      Bind Therapeutics
      Boehringer Ingelheim
      Bristol Mayer Squibb
      Celldex Therapeutics
      Dendreon Corporation
      Eli Lily
      GalaxoSmithKline
      Galena Biopharma
      Genetech
      ImmunoCellular Therapeutics
      ImmunoGen
      Inovio Pharmaceuticals
      Johnson & Johnson
      NeoStem Oncology
      NewLink Genetics
      Northwest Biotherapeutics
      Merck
      Novartis
      Peregrine Pharmaceuticals
      Pfizer
      Roche
      Sanofi
      Seattle Genetics
      Teva

      Market segment by Type, the product can be split into
      Tumor Antigens As Targets of Antibodies
      Development of Antibodies for Clinical Purposes
      Complement Dependent Cytotoxicity (CDC)
      Signal Transduction Changes

      Market segment by Application, split into
      Hospital
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cancer Targeted Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Cancer Targeted Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cancer Targeted Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now